Aflac Incorporated (AFL)

Market Cap	57.35B
Revenue (ttm)	18.93B
Net Income (ttm)	5.44B
Shares Out	549.96M
EPS (ttm)	9.63
PE Ratio	10.83
Forward PE	15.30
Dividend	$2.32 (2.23%)
Ex-Dividend Date	Feb 19, 2025

Volume	1,431,391
Open	104.00
Previous Close	104.51
Day's Range	103.31 - 104.46
52-Week Range	78.62 - 115.50
Beta	0.99
Analysts	Hold
Price Target	102.93 (-1.29%)
Earnings Date	Feb 5, 2025

About AFL

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term ...

• Industry: Insurance - Life
• Sector: Financials
• Founded: 1955
• Employees: 12,785
• Stock Exchange: NYSE
• Ticker Symbol: AFL
• Website: https://www.aflac.com

Financial Performance

In 2024, Aflac's revenue was $18.93 billion, an increase of 1.21% compared to the previous year's $18.70 billion. Earnings were $5.44 billion, an increase of 16.83%.

Analyst Forecast

According to 14 analysts, the average rating for AFL stock is "Hold." The 12-month stock price forecast is $102.93, which is a decrease of -1.29% from the latest price.

Price Target

$102.93

(-1.29% downside)

Analyst Consensus: Hold